These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4061700)

  • 1. Pharmacokinetic interaction of disulfiram and antidepressants.
    Ciraulo DA; Barnhill J; Boxenbaum H
    Am J Psychiatry; 1985 Nov; 142(11):1373-4. PubMed ID: 4061700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of imipramine and desipramine in alcoholics and normal volunteers.
    Ciraulo DA; Barnhill JG; Jaffe JH
    Clin Pharmacol Ther; 1988 May; 43(5):509-18. PubMed ID: 3365915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine.
    Brøsen K; Gram LF
    Eur J Clin Pharmacol; 1989; 37(2):155-60. PubMed ID: 2792169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent inhibition of theophylline metabolism by disulfiram in recovering alcoholics.
    Loi CM; Day JD; Jue SG; Bush ED; Costello P; Dewey LV; Vestal RE
    Clin Pharmacol Ther; 1989 May; 45(5):476-86. PubMed ID: 2721103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cimetidine-imipramine interaction: a case report.
    Miller DD; Macklin M
    Am J Psychiatry; 1983 Mar; 140(3):351-2. PubMed ID: 6829810
    [No Abstract]   [Full Text] [Related]  

  • 6. Imipramine and desipramine disposition in the elderly.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1985 Jan; 232(1):183-8. PubMed ID: 3965690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of elimination of caffeine by disulfiram in normal subjects and recovering alcoholics.
    Beach CA; Mays DC; Guiler RC; Jacober CH; Gerber N
    Clin Pharmacol Ther; 1986 Mar; 39(3):265-70. PubMed ID: 3948467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipramine demethylation and hydroxylation: impact of the sparteine oxidation phenotype.
    Brøsen K; Otton SV; Gram LF
    Clin Pharmacol Ther; 1986 Nov; 40(5):543-9. PubMed ID: 3769385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the kinetics of imipramine and related antidepressants.
    Nagy A
    Acta Psychiatr Scand Suppl; 1980; 280():147-56. PubMed ID: 6931475
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of perphenazine on imipramine metabolism in man.
    Gram LF
    Psychopharmacol Commun; 1975; 1(2):165-75. PubMed ID: 1223997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1984; 36(1):21-6. PubMed ID: 6462958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-pass metabolism of imipramine and desipramine: impact of the sparteine oxidation phenotype.
    Brøsen K; Gram LF
    Clin Pharmacol Ther; 1988 Apr; 43(4):400-6. PubMed ID: 3356084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interaction between neuroleptics and tricyclic antidepressants in the rat.
    Gram LF; Christiansen J; Overo KF
    Acta Pharmacol Toxicol (Copenh); 1974 Sep; 35(3):223-32. PubMed ID: 4479259
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetic properties of the metabolism of imipramine and desipramine in isolated rat hepatocytes.
    Chiba M; Fujita S; Suzuki T
    Biochem Pharmacol; 1990 Jan; 39(2):367-72. PubMed ID: 2302258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cimetidine interaction with imipramine and nortriptyline.
    Henauer SA; Hollister LE
    Clin Pharmacol Ther; 1984 Feb; 35(2):183-7. PubMed ID: 6692646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction.
    Bergstrom RF; Peyton AL; Lemberger L
    Clin Pharmacol Ther; 1992 Mar; 51(3):239-48. PubMed ID: 1544284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of imipramine and desipramine.
    Sallee FR; Pollock BG
    Clin Pharmacokinet; 1990 May; 18(5):346-64. PubMed ID: 2185906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of single-dose pharmacokinetics of imipramine and maprotiline in the elderly.
    Hrdina PD; Rovei V; Henry JF; Hervy MP; Gomeni R; Forette F; Morselli PL
    Psychopharmacology (Berl); 1980; 70(1):29-34. PubMed ID: 6775331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipramine-cimetidine interaction: impairment of clearance and enhanced absolute bioavailability.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1984 Jun; 229(3):702-5. PubMed ID: 6726654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.